Carelabs Co.Ltd (263700) - Total Liabilities

Latest as of September 2025: ₩26.83 Billion KRW ≈ $18.19 Million USD

Based on the latest financial reports, Carelabs Co.Ltd (263700) has total liabilities worth ₩26.83 Billion KRW (≈ $18.19 Million USD) as of September 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Also explore how fast is Carelabs Co.Ltd growing its equity to track the company's year-over-year net asset growth rate.

Carelabs Co.Ltd - Total Liabilities Trend (2016–2024)

This chart illustrates how Carelabs Co.Ltd's total liabilities have evolved over time, based on quarterly financial data. See Carelabs Co.Ltd free cash flow efficiency to measure how efficiently the company converts operating cash flow to free cash.

Carelabs Co.Ltd Competitors by Total Liabilities

The table below lists competitors of Carelabs Co.Ltd ranked by their total liabilities.

Company Country Total Liabilities
Shanyuan Co Ltd
TWO:4416
Taiwan NT$12.95 Billion
Green Plus Co. Ltd
KQ:186230
Korea ₩58.86 Billion
Sungmoon Elect
KO:014910
Korea ₩39.29 Billion
Complete Solaria, Inc
NASDAQ:SPWR
USA $320.66 Million
Ratio Energies LP
TA:RATI-L
Israel ILA768.11 Million
Hoftex Group AG
MU:NBH
Germany €66.62 Million
SMRT Holdings Bhd
KLSE:0117
Malaysia RM16.64 Million
Inalways
TWO:5398
Taiwan NT$70.17 Million

Liability Composition Analysis (2016–2024)

This chart breaks down Carelabs Co.Ltd's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see how much is Carelabs Co.Ltd worth.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric Value Description
Current Ratio 2.29 Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio N/A More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio N/A Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity 0.37 Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets 0.26 Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how Carelabs Co.Ltd's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for Carelabs Co.Ltd (2016–2024)

The table below shows the annual total liabilities of Carelabs Co.Ltd from 2016 to 2024.

Year Total Liabilities Change
2024-12-31 ₩94.81 Billion
≈ $64.25 Million
+1.22%
2023-12-31 ₩93.67 Billion
≈ $63.48 Million
-2.48%
2022-12-31 ₩96.05 Billion
≈ $65.09 Million
-0.26%
2021-12-31 ₩96.30 Billion
≈ $65.26 Million
+184.24%
2020-12-31 ₩33.88 Billion
≈ $22.96 Million
-47.76%
2019-12-31 ₩64.86 Billion
≈ $43.96 Million
-0.01%
2018-12-31 ₩64.87 Billion
≈ $43.96 Million
+296.67%
2017-12-31 ₩16.35 Billion
≈ $11.08 Million
+199.77%
2016-12-31 ₩5.46 Billion
≈ $3.70 Million
--

About Carelabs Co.Ltd

KQ:263700 Korea Health Information Services
Market Cap
$22.35 Million
₩32.98 Billion KRW
Market Cap Rank
#24714 Global
#1765 in Korea
Share Price
₩1700.00
Change (1 day)
-2.86%
52-Week Range
₩1613.00 - ₩6260.00
All Time High
₩30600.00
About

Carelabs Co.,Ltd operates as a healthcare and beauty care platform company in South Korea. The company offers healthcare IT services, such as hospital information services, hospital customer management software, and digital marketing solutions. It provides BABITALK, a plastic surgery information platform; Medijob, which provides human resources to hospitals; VIBE RC, a digital marketing platform;… Read more